Found: 72
Select item for more details and to access through your institution.
Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 751, doi. 10.1007/s10637-012-9885-8
- By:
- Publication type:
- Article
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 921, doi. 10.1007/s00262-010-0818-0
- By:
- Publication type:
- Article
Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 6, p. 831, doi. 10.1002/(SICI)1097-0215(19991210)83:6<831::AID-IJC24>3.0.CO;2-O
- By:
- Publication type:
- Article
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
- Published in:
- 1990
- By:
- Publication type:
- journal article
A randomized phase I Bayesian dose escalation design for the combination of anti-cancer drugs.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 3, p. 196, doi. 10.1002/pst.1618
- By:
- Publication type:
- Article
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 192, doi. 10.1016/j.clpt.2006.05.003
- By:
- Publication type:
- Article
Relationship of systemic exposure to unbound docetaxel and neutropenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 43, doi. 10.1016/j.clpt.2004.09.005
- By:
- Publication type:
- Article
Mechanism-based models for topotecan-induced neutropenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 567, doi. 10.1016/j.clpt.2004.08.008
- By:
- Publication type:
- Article
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 1, p. 38, doi. 10.1016/j.clpt.2004.03.003
- By:
- Publication type:
- Article
Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 5, p. 448, doi. 10.1016/j.clpt.2004.01.001
- By:
- Publication type:
- Article
Disposition of polyoxyethylated excipients in humans: Implications for drug safety and formulation approaches.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 5, p. 509, doi. 10.1016/j.clpt.2003.08.004
- By:
- Publication type:
- Article
Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 4, p. 364, doi. 10.1016/S0009-9236(03)00222-4
- By:
- Publication type:
- Article
Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 265, doi. 10.1067/mcp.2002.126741
- By:
- Publication type:
- Article
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 5, p. 491, doi. 10.1016/S0009-9236(99)70068-8
- By:
- Publication type:
- Article
Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 2, p. 396, doi. 10.1038/mt.2014.215
- By:
- Publication type:
- Article
Low dose methotrexate and vinblastine, given weekly to patients with desmoid tumours, is associated with major toxicity.
- Published in:
- Sarcoma, 2003, v. 7, n. 3/4, p. 153, doi. 10.1080/13577140310001644779
- By:
- Publication type:
- Article
Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group.
- Published in:
- Sarcoma, 2000, v. 4, n. 1/2, p. 31, doi. 10.1155/S1357714X00000062
- By:
- Publication type:
- Article
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Effects of St. John's Wort on Irinotecan Metabolism.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 16, p. 1247, doi. 10.1093/jnci/94.16.1247
- By:
- Publication type:
- Article
Progression of paclitaxel-induced neuropathy following discontinuation of treatment.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 2, p. 383, doi. 10.1007/s10549-019-05305-w
- By:
- Publication type:
- Article
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 4, p. 309, doi. 10.1007/s002800000215
- By:
- Publication type:
- Article
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 2, p. 167, doi. 10.1007/s002800000134
- By:
- Publication type:
- Article
Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck.
- Published in:
- Head & Neck, 1992, v. 14, n. 4, p. 273, doi. 10.1002/hed.2880140403
- By:
- Publication type:
- Article
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 196, doi. 10.1016/j.molonc.2012.01.009
- By:
- Publication type:
- Article
Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 323, doi. 10.1634/theoncologist.2012-0334
- By:
- Publication type:
- Article
Effects of Mannose-Binding Lectin Polymorphisms on Irinotecan-Induced Febrile Neutropenia.
- Published in:
- Oncologist, 2010, v. 15, n. 10, p. 1063, doi. 10.1634/theoncologist.2010-0033
- By:
- Publication type:
- Article
(Pre-)Clinical Pharmacology and Activity of Pazopanib, a Novel Multikinase Angiogenesis Inhibitor.
- Published in:
- Oncologist, 2010, v. 15, n. 6, p. 539, doi. 10.1634/theoncologist.2009-0274
- By:
- Publication type:
- Article
Other Endpoints in Screening Studies for Soft Tissue Sarcomas.
- Published in:
- Oncologist, 2008, v. 13, p. 27, doi. 10.1634/theoncologist.13-S2-27
- By:
- Publication type:
- Article
Other Endpoints in Screening Studies for Soft Tissue Sarcomas.
- Published in:
- Oncologist, 2008, v. 13, p. 27, doi. 10.1634/theoncologist.13-S2-27
- By:
- Publication type:
- Article
A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 467, doi. 10.1634/theoncologist.2008-0065
- By:
- Publication type:
- Article
The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas.
- Published in:
- Oncologist, 2007, v. 12, n. 11, p. 1351, doi. 10.1634/theoncologist.12-11-1351
- By:
- Publication type:
- Article
Flat-Fixed Dosing Versus Body Surface Area-Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?
- Published in:
- Oncologist, 2007, v. 12, n. 8, p. 913, doi. 10.1634/theoncologist.12-8-913
- By:
- Publication type:
- Article
Improved Insight into Resistance Mechanisms to Imatinib in Gastrointestinal Stromal Tumors: A Basis for Novel Approaches and Individualization of Treatment.
- Published in:
- Oncologist, 2007, v. 12, n. 6, p. 719, doi. 10.1634/theoncologist.12-6-719
- By:
- Publication type:
- Article
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 291, doi. 10.1634/theoncologist.12-3-291
- By:
- Publication type:
- Article
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 5, p. 974, doi. 10.1080/02841860701666089
- By:
- Publication type:
- Article
Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048372
- By:
- Publication type:
- Article
Rational Design of New Tumoractivated[sup TM] Cytotoxic Agents.
- Published in:
- Oncology, 1999, v. 57, p. 9, doi. 10.1159/000055263
- By:
- Publication type:
- Article
Optimal Control of Acute Cisplatin-lnduced Emesis.
- Published in:
- Oncology, 1996, v. 53, n. S1, p. 56, doi. 10.1159/000227642
- By:
- Publication type:
- Article
Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944
- By:
- Publication type:
- Article
4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 560, doi. 10.1111/bcp.12707
- By:
- Publication type:
- Article
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-429
- By:
- Publication type:
- Article
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3κ.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-429
- By:
- Publication type:
- Article
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.
- Published in:
- 2014
- By:
- Publication type:
- journal article
New Guidelines to Evaluate the Response to Treatment in Solid Tumors.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 19, p. 1393, doi. 10.1093/jnci/88.19.1393
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Docetaxel: Recent Developments.
- Published in:
- Clinical Pharmacokinetics, 2006, v. 45, n. 3, p. 235, doi. 10.2165/00003088-200645030-00002
- By:
- Publication type:
- Article